Pyridine

Pyridine

SCHEMBL7476776

NCCNc1ccc([N+](=O)[O-])cn1.c1ccncc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
POLB P06746 2/20 0.58
KMT2A Q03164 6/20 0.52
MEN1 O00255 5/20 0.52
MAPT P10636 7/20 0.51
LMNA P02545 2/20 0.51
RAB9A P51151 4/20 0.49
NPC1 O15118 3/20 0.49
ALDH1A1 P00352 3/20 0.49
GAA P10253 2/20 0.49
DPP4 P27487 1/20 0.47
MKNK1 Q9BUB5 1/20 0.47
MKNK2 Q9HBH9 1/20 0.47
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30014816 0.90 SMN1; SMN2 (0.60) SMN1; SMN2POLBKMT2AMEN1MAPT
SCHEMBL1146057 0.90 SMN1; SMN2 (0.60) SMN1; SMN2POLBKMT2AMEN1MAPT
Hydrochloric Acid SCHEMBL6638580 0.89 SMN1; SMN2 (0.58) SMN1; SMN2POLBKMT2AMEN1MAPT
Oxalic Acid SCHEMBL7426081 0.86 POLB (0.57) SMN1; SMN2POLBKMT2AMEN1MAPT
SCHEMBL8353859 0.85 POLB (0.53) SMN1; SMN2POLBKMT2AMEN1MAPT
SCHEMBL6087660 0.83 DPP4 (0.57) SMN1; SMN2POLBKMT2AMEN1MAPT
SCHEMBL5099213 0.82 SMN1; SMN2 (0.57) SMN1; SMN2POLBKMT2AMEN1MAPT
SCHEMBL3941650 0.81 SMN1; SMN2 (0.56) SMN1; SMN2POLBKMT2AMEN1MAPT
SCHEMBL7363076 0.79 SMN1; SMN2 (0.60) SMN1; SMN2POLBKMT2AMEN1MAPT
SCHEMBL9143702 0.78 SMN1; SMN2 (0.63) SMN1; SMN2POLBKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002032896-A1 FURAZANYL-TRIAZOLE DERIVATES FOR THE TREATMENT OF DISEASES NOVO NORDISK A/S (DK) 2002-04-25 WO disclosed